McGill researchers鈥� findings show that may be the case
听
Published on: 24 Jan 2020
Study sheds light on longstanding debate
听
Researchers have known for decades that inflammation accompanies Alzheimer鈥檚 disease (AD) brain lesions. Several early studies suggested that 鈥渟uper-aspirins鈥� or Nonsteroidal anti-inflammatory drugs (NSAID) could help avoid the disease. However, after clinical trials showed that NSAIDs don鈥檛 help patients who already have AD symptoms, doctors wondered whether these drugs could still be helpful to people who were at risk of developing the disease, but weren鈥檛 yet showing symptoms.
Category:
Published on: 5 Apr 2019
Dr. Claudio Cuello, Professor and inaugural Charles E. Frosst/Merck endowed Chair in Pharmacology at 香蕉视频鈥檚 Faculty of Medicine is among a group of 48 leading biomedical and health scientists whose work is being recognized with election to the prestigious British Academy of Medical Sciences, announced on May 10.听 The new Fellows have been elected for their outstanding contributions to biomedical and health science, leading research discoveries, and translating developments into benefits for patients and the wider society.
Category:
Published on: 10 May 2018
Partners agree to share resources, establish steering committee for closer collaboration
On April 20, 2018, Canadian, Chinese and Cuban neuroscience institutes strengthened an existing partnership with the signing of a memorandum of understanding in Chengdu, China.
Partners in the agreement include The Montreal Neurological Institute and Hospital (The Neuro) of 香蕉视频, The Cuban Neuroscience Center, The University of Electronic Sciences and Technology of China, The West China Hospital, and The Tianfu New Area of Chengdu (TFNA).
Category:
Published on: 23 Apr 2018
You鈥檙e about to turn 60, and you鈥檙e fretting. Your mother has had Alzheimer鈥檚 disease since the age of 65. At what age will the disease strike you? A Canadian study published in JAMA Neurology shows that the closer a person gets to the age at which their parent exhibited the first signs of Alzheimer鈥檚, the more likely they are to have amyloid plaques, the cause of the cognitive decline associated with the disease, in their brain.
Category:
Published on: 26 Feb 2018
Doctors who work with individuals at risk of developing dementia have long suspected that patients who do not realize they experience memory problems are at greater risk of seeing their condition worsen in a short time frame, a suspicion that now has been confirmed by a team of 香蕉视频 clinician scientists.
Category:
Published on: 15 Feb 2018
New research has drawn a link between changes in the brain鈥檚 anatomy and biomarkers that are known to appear at the earliest stages of Alzheimer鈥檚 disease (AD), findings that could one day provide a sensitive but non-invasive test for AD before cognitive symptoms appear.
Scientists have known for some time that one of the first signs of AD is buildup of amyloid-Beta and tau proteins in the brain. They have also known that the hippocampus atrophies and loses volume in some AD patients years before cognitive decline.
Category:
Published on: 19 Dec 2017
Volume in brain region linked to physiological changes characteristic of AD
New research has drawn a link between changes in the brain鈥檚 anatomy and biomarkers that are known to appear at the earliest stages of Alzheimer鈥檚 disease (AD), findings that could one day provide a sensitive but non-invasive test for AD before cognitive symptoms appear.
Category:
Published on: 19 Dec 2017
Imagine if doctors could determine, many years in advance, who is likely to develop dementia. Such prognostic capabilities would give patients and their families time to plan and manage treatment and care. Thanks to artificial intelligence research conducted at 香蕉视频, this kind of predictive power could soon be available to clinicians everywhere.
Category:
Published on: 22 Aug 2017
Microglia, critical to Alzheimer鈥檚 research, can now be produced artificially
The quest for better understanding of Alzheimer鈥檚 disease (AD) has a powerful new tool at its disposal 鈥� the ability to artificially generate brain cells that have been shown to play an important role in the disease function.
Category:
Published on: 16 May 2017
Researchers from the Montreal Neurological Institute and Hospital at 香蕉视频 and the MUHC, have received a total of over $4.5 M in funding, for innovative projects to accelerate diagnosis and drug discovery for diseases of the brain, including Alzheimer鈥檚.
CQDM, Brain Canada Foundation and the Ontario Brain Institute made the announcement at the annual conference of the Canadian Association for Neuroscience in Vancouver. Six Canadian research teams share a total investment of $ 10 million, through the strategic "Focus on Brain" initiative.
Category:
Published on: 10 Jun 2015
Pages
